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INTRODUCTION
INTRODUCTION
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Pregnancy  is  a  time  when  serial  metabolic  adaptations  in  maternal  fuel 
metabolism and hormones occur, in order to accommodate a rapidly growing tissue 
transplant, the conceptus. Subtle perturbation in these changes can have implication 
not only for the index pregnancy but also for the future generation.
Diabetes is the most  common medical  complication of pregnancy. Women 
can be separated into those who were known to have diabetes before pregnancy - 
PRE GESTATIONAL / OVERT DIABETES and those diagnosed during pregnancy 
- GESTATIONAL DIABETES MELLITES (GDM). GDM as a concept began in 
1964 when O’Sullivan and Mahan performed the oral glucose tolerance test.
Ethnically Indian women have high prevalence of diabetes and the relative 
risk of developing GDM in Indian women is 11.3 times compared to white women, 
necessitating universal screening for glucose intolerance during pregnancy in India. 
Screening for GDM is an example of how timely intervention that costs very little 
and enables easy management of the condition can help in reducing the risk of both 
mother and child becoming diabetic at a later stage. 
Several studies have established that elevated glucose levels can be detected 
through screening even as early as 16th week of pregnancy and that the condition 
shows up at all the trimesters. 2 to 2.5 % of GDM prevalence was found in the 16th 
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week, 2.5 to 3 % cases were detected during the 24th week and 3% in the 32nd week, 
recorded during the Tamil Nadu programme. This is being reviewed in this study.
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O’Sullivan1 and Mahan  in  their  classical  study of  1964,  analyzed glucose 
response over 3 hours to a 100 grams oral glucose challenge, performed on venous 
whole blood by the Somogyi – Nelson (S – N) technique, in 752 healthy pregnant 
women in Boston.  Gestational diabetes mellitus was diagnosed when two or more 
blood  glucose  concentrations were  more  than  2  SD  above  the  mean.  The 
investigators'  initial  interest  was  in  the  ability of  such  a  finding  to  predict  the 
development of diabetes in later life.  2.5% of the population was defined as having 
GDM in his study.
Diagnosing GDM and instituting aggressive management of the mother are 
intended to reduce or eliminate the perinatal, neonatal and long term complications 
in the offspring.  O’Sullivan and Mahan’s criteria were too lax for the identification 
of people at risk for perinatal morbidity associated with carbohydrate intolerance. 
 
The  National  Diabetes  Data  Group  (NDDG)  revised  the  criteria  in  1979, 
calculating the equivalent glucose oxidase plasma values from the original data2 by 
using a conversion factor of 1.14.  Technical modification of that conversion have 
been  recommended  by  Carpenter  and  Coustan3 in  1982,  as  being  more 
representative of the true plasma glucose determination.  This modification results in 
a lowering of all glucose levels in the 3 hour OGTT, thus increasing the sensitivity 
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of the test.   By using the lower modified  criteria,  overall  incidence  of  GDM is 
increased  by  56%.   Sacks  &  associates  conducted  simultaneous  determinations 
using  the  S  –  N  and  glucose  oxidase  techniques  and  discovered  that  NDDG 
conversions were above the 95% confidence limits for all but the fasting sample, 
whereas  the  Carpenter  &  Couston  conversions  were  always  within  the  95% 
confidence  intervals4.  Data  on  the  modified  criteria  was  presented  at  the  4th 
International  Workshop on gestational  diabetes.  Infants  of  women meeting these 
lower  criteria  are  at  risk  for  potential  morbidity  including macrosomia.   Hence, 
Carpenter and Coustan criteria was adopted for diagnosis. 
Table 3. Diagnostic Criteria for GDM Using the 100 g OGTT
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O’Sullivan21* NDDG48**
Carpenter and 
Coustan49**
Fasting
1-hour
2-hour 
3-hour
90 mg/dl
165 mg/dl 
145 mg/dl
125 mg/dl
105 mg/dl
190 mg/dl
165 mg/dl 
145 mg/dl
95 mg/dl
180 mg/dl 
155 mg/dl 
140 mg/dl
The diagnosis requires any two values to meet or exceed those listed 
above.
* Venous whole blood, Somogyi-Nelson analysis.
** Plasma, glucose oxidase.
The NDDG criteria are recommended for the diagnosis of GDM by 
ACOG and the Expert Committee on the Diagnosis and Classification of 
Diabetes Mellitus.
The  4th International  Workshop5 on  GDM  defined  cut  off  values  for  the 
controversial 75 grams OGTT in pregnancy.  The cut off values were arbitrarily 
defined based on the mean plus 1.5 SD of the OGTT values in a study of over 3500 
patients.  Greater experience in the use of 75 grams OGTT and maternal & infant 
outcomes data will be needed to define better cut off values for this test.  Data are 
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becoming increasingly available to suggest that a single abnormal value on GTT 
may predict perinatal outcome.  Tallerigo et al examined the neonatal outcome in 
249 women and found that 2 hour plasma glucose concentration after 100 grams 
OGTT significantly correlated with infants’ birth weight.
Because of lack of reproducibility of the glucose tolerance test, together with 
the  discrepancies  in  the  number  of  abnormalities,  much  effort  has  gone  into 
establishing simpler diagnostic criteria for GDM.  Neither glycated hemoglobin nor 
fructosamine is sufficiently sensitive for identification of women with GDM.  
Stangenberg et  al6 examined 6969 random plasma glucose levels for  1500 
pregnant women without any signs and symptoms of diabetes with a threshold of 
120mg/dl.  11.6% of them had abnormal  glucose values and 5.8% had abnormal 
glucose tolerance test result. The overall prevalence of GDM identified was only 
0.9%, which was substantially less than that in O’Sullivan’s study. This suggests 
that a protocol that uses random plasma glucose levels may have a substantial false 
negative rate.
The  second  International  Workshop  on  GDM  in  1985  defined  GDM  as 
“Carbohydrate  intolerance  of  varying  severity  with  onset  and  first  recognition 
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during the present pregnancy” and this is the current widely accepted definition of 
gestational diabetes mellitus.  It was concluded that, the best screening test was 50 
grams, 1 hour glucose challenge test and 1 hour plasma glucose determination in 
excess of 140 mg/dl constitutes a positive screen and requires the performance of 
the traditional 100 grams OGTT for confirmation of GDM. 
Naylor et al7 evaluated data on over 3000 pregnant women and developed a 
scoring system to determine the risk of GDM based on age, body mass index and 
race.  The American Diabetes Association position statement suggests that it is not 
cost effective to screen women at low risk.  This new policy has been controversial, 
however, with some suggesting that 10% of patients with GDM would be missed if 
all women were not screened. Owen and colleagues (1995) surveyed in USA and 
found that  97% were using universal  screening test  between 24 to 28 weeks of 
gestation.              
 
Gabbe8 in 1980 in his masterly  review titled “Management  of Diabetes  in 
Pregnancy,  six decades of  experience” traced the history of  management  of  this 
condition and identified four distinct periods as shown below:        
Aim of Care: 
     1921 to 1940     -       Avoid ketoacidosis
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     1941 to 1970     -       Team care / early delivery
     1971 to 1976     -       Fetal surveillance
     1976 to 1992     -       Aim for normoglycemia
Glucose traditionally has been used as the marker for GDM because of its 
ease  of  measurement  and  test  reproducibility.   It  is  now clear  that  alteration  in 
insulin  secretion,  insulin  sensitivity  and  carbohydrate,  fat  and  amino  acid 
metabolism are  all  intrinsic  abnormalities  in the state  that  we have to accept  as 
GDM.  Developing more sensitive indices for prediction of perinatal morbidity may 
require  either  intensification  of  glycemic  criteria  or  the  inclusion  of  more 
sophisticated metabolic measurements.
According to ACOG (1994) the sensitivity of screening may be improved by 
using a 130 mg/dl threshold rather than 140 mg/dl to design an abnormal response to 
a 50 gm test.  Use of low threshold value may increase the detection of GDM from 
90 to 100 per cent but at an expense of subjecting 25% of pregnant women to 3 hour 
OGTT. Women with previous history of GDM may benefit from earlier screening. 
If screening in early pregnancy yields a normal test, subsequent screening should be 
performed at 24 to 28 weeks according to ACOG (1994).  
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David Stamilio et al9 in January 2004, performed a retrospective cohort study 
of 1825 eligible pregnant women among a cohort of 1998 patients.  Patients were 
screened for GDM with the one hour 50 grams OGCT at 24 to 28 gestational weeks. 
False positive GCT was defined as a result ≥ 135 mg/dl followed by a normal 3 
hours OGTT.   Comparison was  made between negative GCT and false  positive 
GCT  for  a  composite  perinatal  outcome.  Variables  that  included  were  fetal 
macrosomia, antenatal death, shoulder dystocia, chorioamnionitis, pre ecclampsia, 
NICU admission,  caesarean  delivery  and post  partum endometritis.   The  results 
were 164 patients with a false positive GCT and 50 patients with GDM.  The false 
positive GCT cohort on average was older, was of higher parity, had a higher BMI 
and more frequently had chronic hypertension,  sickle cell  trait  and elevated mid 
trimester hCG.  False positive GCT was more frequently associated with adverse 
perinatal  outcome  including  composite  perinatal  outcome  (odds  ratio  5.96), 
macrosomia more than 4.5 kg (odds ratio 3.66), antenatal death (odds ratio 4.61), 
shoulder  dystocia (odds ratio 2.85),  endometritis  (odds ratio 2.18) and caesarean 
delivery (odds ratio 1.76).
The  University  of  Pennsylvania  Institutional  Review Board  approved  this 
study.  So patients with false positive GCT could benefit from additional therapies 
such as more intensive fetal monitoring, nutritional counseling or a diabetic diet. 
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The result of this study suggests that having a false positive GCT is an independent 
risk factor for adverse perinatal outcome. 
Rey et al10 reported that patients with an abnormal GCT and a single elevated 
value  on  the  OGTT  are  at  increased  risk  for  fetal  macrosomia,  neonatal 
hypoglycemia  and neonatal  hyperbillirubinemia.  Okun et  al  showed that  patients 
with an abnormal GCT and no elevated values on the OGTT are at increased risk for 
fetal macrosomia.
 
Sun et al11, in 1995 did a prospective study on the relationship between 50 
grams GCT and pregnancy outcome. 50 grams OGCT was performed 622 pregnant 
women and 75 grams OGTT was further done on subjects with screening test value 
of ≥ 140 mg/dl.  16.56% (103) had elevated GCT values, among whom 32 were 
identified  as  having  gestational  impaired  glucose  tolerance  and  12  GDM  by 
confirmatory test of 75 gms OGTT.   Sensitivity was 42.72%.  The incidence of 
PROM, fetal macrosomia, operative deliveries and perinatal morbidity were higher 
in  women  with  GIGT  (Gestational  impaired  glucose  tolerance)  /  GDM than  in 
women without GIGT / GDM.  It suggests that 50 grams GCT is the ideal method of 
screening for GDM and should be performed on all pregnant women.
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Lao et al12 in 2002 in Queen Mary Hospital, Hongkong, studied on 461 large 
for gestational age babies, the relationship between WHO category of IGT (2 hour 
value of 75gms OGTT at 140 mg/dl)  and outcome in LGA infants to determine 
whether IGT affects perinatal morbidity in addition to affecting infant size.  OGT 
group had significantly higher mean maternal age, pre pregnancy weight and body 
mass index, but no difference in infant’s gestational age and birth weight.  However 
IGT group  had  increased  incidence  of  Erb’s  palsy,  meconium aspiration,  photo 
therapy, sepsis and shoulder dystocia.
According to Leslie et al13 1978, there is also a definite increased incidence of 
congenital malformations in infants born to diabetic mothers. Good diabetic control 
however reduced the incidence of congenital malformations even in patients with 
vascular complications. This indicates that the level of blood sugar elevation is a 
factor that influences the incidence of congenital malformation. Also, confirmed by 
the fact that more infants with congenital malformation are born of women with 
high HbA1C levels before pregnancy, than of women who have normal levels.
In  1992,  Rizvi  et  al14,  subjected  2230  antenatal  women,  irrespective  of 
gestational  age,  to a 75 grams glucose challenge followed 2 hrs later by plasma 
glucose determination. The test was repeated at 28 to 32 wks of gestation for those 
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who had an abnormal initial screen at less than 28 wks of gestation followed by a 
normal GTT and for those who had a high risk factor for gestational diabetes even 
though the initial screen at < 28 wks was normal. The initial GCT was abnormal 
(2hr plasma glucose >140 mgs) in 8.6 % of screened population. An OGTT on these 
patients,  revealed  prevalence  for  the  entire  population  of  3.5%  of  gestational 
diabetes  and 1.9% of  impaired  glucose  tolerance  based  on modified  O’Sullivan 
criteria. Patients with abnormal GTT were older, had higher parity, a past history of 
macrosomia and a family history of DM compared to controls.
 
They also had a higher incidence of preterm labor and cesarean section. In the 
neonates,  hypoglycemia  and hyperbillirubinemia  were similarly  higher.  The fetal 
abnormality  rate  was  5.6% and the  perinatal  mortality  was  28/1000,  which  was 
higher than controls. Improvement in cost effectiveness of screening programs was 
adjudged possible by avoiding GTT in patients with 2 hr plasma glucose values 
> 170mgs after 75grams oral glucose challenge for screening. 
Schmidt and Duncan et al15 evaluated American Diabetes Association (ADA) 
and  WHO  diagnostic  criteria  for  GDM  against  pregnancy  outcomes  in  4977 
Brazilian women in 2001. All were subjected to a 2 hr 75 grams OGTT between 24 
to 28 wks of gestational age and were followed to delivery. New ADA criteria for 
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GDM require two plasma glucose values ≥ 5.3mmol/l (fasting), ≥ 10mmol/l (1 hr) 
and ≥ 8.6mmol/l (2 hr). WHO criteria require a plasma glucose ≥ 7mmol/l (fasting) 
OR ≥7.8mmol/l  (2 hr).  They concluded GDM based on a 2 hr 75 grams OGTT 
defined by either WHO or ADA criteria predicts adverse pregnancy outcomes.
De Sereday and Damiano et al16 determined which of ADA or WHO plasma 
glucose criteria for GDM best predicts poor fetal outcome. They also determined 
whether an alternative cut off point would result in increased predictive value and 
greater diagnostic effectiveness in pregnancies at risk for GDM. They concluded 
that the standard 2 hr cut off  value of 140 mg/dl  for the 75 grams test,  as now 
recommended by WHO, was optimal for predicting macrosomia. The 2 hr, 75 grams 
OGTT  value  using  a  cut  off  point  of  119  mg/dl  had  equivalent  sensitivity, 
specificity and positive predictive value. In contrast, the 100 grams OGTT had much 
lower levels of sensitivity but higher specificity and higher positive predictive value. 
Vijayam Balaji et al17 screened 507 pregnant women with a 75 gms glucose 
challenge test. Diagnosis was based on WHO criteria of a 2 hr plasma glucose level 
≥  140mg/dl.  In  the  fasting  sample,  in  addition  to  plasma  glucose,  HbA1C  was 
measured. Among the women screened 50.3% were in 1st trimester of pregnancy. In 
this group 16.96% had GDM. Applying the cut off  of 6% for  A1C levels,  these 
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women were categorized into 4 groups.  Group 1:  GCT positive and A1C ≥ 6%. 
Group 2:  GCT positive and A1C <6%. Group 3:  GCT negative and A1C ≥ 6%. 
Group 4: GCT negative and A1C <6%. They found out that, women with an early 
diagnosis of GDM, in the first half of pregnancy, represent a high risk sub group 
within  the  GDM  population  and  have  an  increased  incidence  of  obstetric 
complications, recurrent GDM in subsequent pregnancies, and future development 
of type 2 diabetes. Hence, women with GDM in early pregnancy could benefit from 
earlier metabolic control. Also pregnant women with normal GCT but A1C >6% and 
women with A1C values between 5.3 and 6% require utmost attention. 
In 2005, Seshiah et al18, studied the merits and demerits of different screening 
and diagnostic procedures that are used at present and to find a one step procedure 
which serves both as a screening as well  as  a diagnostic test.  He subjected 891 
pregnant women in the 2nd and 3rd trimester to a 50 grams GCT, and blood sample 
was collected after 1 hr. All of them, irrespective of the glucose value after the GCT, 
were  instructed  to  come  back  after  3  days  for  a  subsequent  75  gms  OGTT 
recommended by WHO. Among them 144 (16.2%) were diagnosed as GDM as per 
the WHO criteria of 2 hr post plasma glucose (PPG) ≥ 140mg/dl. Analysis of these 
GDM cases revealed that, 113 (78.5%) had the initial 50 grams value > 130 mg/dl 
whereas potential 31 cases (21.5% of total GDM cases) had the 50 grams 1 hr value 
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below the  cut  off  level  of  130 mg/dl.  He concluded that  diagnosis  of  GDM by 
OGTT based on initial  screening leaves 21.5% undiagnosed and that GCT lacks 
specificity  (41.8%).  The  2  step  procedure  of  screening  with  GCT  and  then 
diagnosing GDM based on the cut  off  values with 100 g or  75 g OGTT is not 
practical.  Hence,  he suggested  a  single  glucose challenge test  with 75 g of  oral 
glucose load and diagnosing GDM if 2 hr PPG is ≥ 140 mg/dl as recommended by 
WHO. This method serves both as a one step screening and a diagnostic procedure, 
and is easy to perform besides being economical. 
In 2007, C.Anjalakshi et  al19,  undertook a study, to elucidate a test  that is 
casual, patient friendly and reliable to diagnose GDM. In this study a total of 800 
pregnant women underwent 75 grams glucose challenge test irrespective of the time 
of the last meal and their 2 hr plasma glucose was estimated. They also underwent a 
2 hr 75 grams OGTT recommended by WHO after 72 hrs. There was no statistically 
significant difference in the glycemic profile between GCT and WHO OGTT in the 
diagnosis  of  GDM.  In  conclusion,  GCT performed  irrespective  of  the  last  meal 
timing, is a patient friendly approach and causes least disturbance in the pregnant 
women’s routine activities. 
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V  Seshiah,  V  Balaji  and  Madhuri  S  Balaji20,  conducted  a  prospective 
screening for GDM in the urban (Chennai city), semi urban (Saidapet taluk) and 
rural (Thiruvallur district) areas. It included 4151, 3960 and 3945 pregnant women 
in the urban, semi urban and rural areas respectively and they underwent a 75 grams 
glucose  challenge  test  in  the  fasting  state  irrespective  of  their  gestational  age. 
Diagnosis of GDM was made if the 2 hr plasma glucose was ≥ 140 mg/dl (WHO 
criteria). 1679 patients (16.55%) were detected to have GDM. The prevalence of 
GDM in the urban, semi urban and rural area was 739 (17.8%), 548 (13.8%) and 
392 (9.9%) respectively. The prevalence of GDM was significantly lower in the 
rural area (p<.0001) when compared to other areas. GDM was diagnosed in 1204 
(72%)  pregnant  women  in  the  first  visit  and  the  remaining  475  (28%)  in  the 
subsequent visits. In this study among the GDM women from all the three areas, 
12.4%  were  detected  within  16  weeks,  23%  between  17  and  23  weeks  and 
remaining 64.6% more than 24 weeks of gestation. There was a significant increase 
in the prevalence of GDM as the age and BMI increased. The prevalence of GDM in 
the physically inactive group was found to be 19.1%, 16.6% and 12.1% whereas it 
was 17.6%, 12.8% and 9.7% in the physically active group. Positive family history 
of diabetes was present in 25%. On univariate analysis, they observed in all the three 
areas,  that  age ≥ 25 yrs,  BMI ≥ 25kg/sq.m and family  history of  diabetes  were 
significantly associated with the prevalence of GDM.
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Umesh  Dashora  and  Vandana  Dashora21 tested  564  patients  attending  the 
antenatal clinic of Ibra Regional Referral Hospital of Oman for glucose intolerance 
by  glucose  tolerance  test  using  75 grams glucose  (WHO criteria).  The  test  was 
performed at booking. If the results are normal, the test was repeated 2 or 3 times at 
2 month intervals, the last  being at the 7th month of pregnancy. They found that 
21.3% of pregnant women had GDM – 1.1% had high fasting values (≥ 110mg/dl) 
and 20.2% had high post glucose values (≥ 140mg/dl). Over 88% of the patients 
with  GDM were  diagnosed  before  the  7th month  of  pregnancy.  10% of  women 
required a second test and 2.5% were diagnosed only at the third test. Birth weight 
of the children in the GDM group was 3.13 kg compared with 2.9 kg in the non 
diabetic group. Hence early and multiple screening for GDM has the potential to 
increase detection of GDM and to favorably influence pregnancy outcome.
V Seshiah and A Cynthia22,  undertook a study to assess the merits of care 
given to women in whom GDM was diagnosed in different weeks of gestation and 
to  find  out  the  ideal  period  of  screening  in  women  with  history  of  high  risk 
pregnancies. A total of 207 pregnant women irrespective of the trimester referred for 
diabetes in pregnancy, underwent a 75 grams oral glucose challenge test and GDM 
was diagnosed if 2 hr plasma glucose ≥ 140 mg/dl.  A1C was estimated in all of 
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them.  Women  who failed  to  respond  to  medical  nutrition  therapy  were  advised 
insulin and the dose titrated to maintain fasting plasma glucose < 90mg/dl and 2 hr 
plasma glucose < 120 mg/dl.
Among them, 87 were diagnosed as GDM. The gestational week at diagnosis 
was  ≤ 12 in  41.4% women (group 1),  between 13 and 23 in  20.7% (group 2), 
between 24 and 30 in 17.2% (group 3) and beyond 30 weeks of gestation in 20.7% 
(group 4). The birth weight of babies born to women with normal glucose tolerance 
was 3.28 ± 0.5 kg. The birth weight of babies born to GDM women in group 1, 
group 2, group 3 and group 4 was 3.15, 3.09, 3.32 and 3.51 respectively. Group 1 
women in spite of the history of high risk pregnancies, delivered babies appropriate 
for  gestational  age  like  normal  glucose  tolerance  women.  Screening in  the  first 
trimester of pregnancy and institution of therapy is advisable in women with high 
risk pregnancies.
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OVERVIEW OF DIABATES IN PREGNANCY
                                                                                                         
DEFINITION OF GESTATIONAL DIABETES:
Carbohydrate intolerance of variable severity with onset or first recognition 
during the present pregnancy. Pregnancy is a form of stress that can cause latent 
diabetes to manifest. In most of these cases the carbohydrate intolerance will revert 
by the end of puerperium but this manifestation may be the first indication of 
diabetes yet to come.
 CLASSIFICATION OF DIABETES DURING PREGNANCY
Diabetes  mellitus  has  been  classified  recently  by  the  American  Diabetes 
Association (ADA) on the basis of etiology into the following categories.
    Type 1 diabetes mellitus          : Immune mediated DM
                                                     : Idiopathic DM
    Type 2 diabetes mellitus          : Relative rather than absolute insulin deficiency
27
    Impaired glucose homeostasis : Impaired fasting glucose
                                                     : Impaired glucose tolerance
    Gestational diabetes mellitus   : Glucose intolerance in pregnancy
    Other specific types                 : DM due to specific etiologies
- Genetic defects of beta cell function
- Genetic defects of insulin action
- Disease of exocrine pancreas
- Endocrinopathies
- Drug or chemical induced
- Infection
- Uncommon forms of immune related diabetes
- Other genetic syndromes
Type 1 diabetes mellitus
It is also called as insulin dependent diabetes mellitus or juvenile diabetes. It 
is due to cell mediated immune destruction of beta cells of pancreas or can be of 
unknown etiology. There is an HLA association, gene being located on chromosome 
6.
Type 2 diabetes mellitus
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It is also called as non insulin dependent diabetes mellitus or maturity onset 
diabetes.  It  is  due  to  an  abnormality  in  insulin  secretion  and  peripheral  insulin 
resistance. Most of the patients are obese. There is no HLA association, but there is 
a strong familial occurrence.
Impaired glucose homeostasis
Impaired fasting glucose – fasting glucose is higher than normal, but less than 
diagnostic.  Impaired  glucose  tolerance  –  plasma  glucose  following  a  75grams 
challenge is higher than normal, but less than diagnostic.
GESTATIONAL DIABETES MELLITES – EPIDEMIOLOGY
Incidence
It  is  variously estimated  that  3 to 5 % of pregnancies are complicated by 
diabetes.  Approximately 0.2 to 0.5 % of all  pregnancies occur in women with a 
preexisting diagnosis of  type 1 diabetes and a similar number have preexisting type 
2  diabetes  mellitus.  An  additional  1  to  6  %  of  women  will  develop  sufficient 
hyperglycemia during pregnancy to meet the criteria for a diagnosis of gestational 
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diabetes.  Of  those  women  with  GDM,  20  and  50%  will  subsequently  develop 
diabetes mellitus. 
           
Criteria for diagnosis of GDM
Care must be taken not to over diagnose maternal diabetes. It is preferable to 
describe women with abnormal screening test as having impaired glucose tolerance 
during pregnancy or gestational carbohydrate intolerance, rather than using the term 
diabetes, since final definition depends upon re-evaluation 6 to 12 wks post partum.
Maternal influences
Detailed  studies  of  many  GDM  subjects  have  disclosed  considerable 
phenotypic  and  genotypic  heterogeneity.  Obesity  and  advanced  maternal  age 
increase the risk of GDM. GDM is commonly regarded as a forerunner of NIDDM. 
Maternal transmission of diabetes that is linked to mutations in mitochondrial DNA 
has  been  described  and  increased  occurrence  of  HLA  antigen  DR3  and  DR4 
associated with GDM has been found. 
 
Freinkel formulated the hypothesis of “Fuel mediated teratogenesis “, which 
states  that  maternal  fuels  may  influence  development  of  the fetus  by  modifying 
phenotypic  gene  expressions.  The  risk  of  development  of  NIDDM is  greater  if 
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mother  had  diabetes  during  pregnancy.  Predisposition  to  childhood  obesity  and 
impaired  glucose  tolerance  is  linked to  prenatal  metabolic  factors.  The  chain  of 
events is depicted as, 
                                             Increased maternal fuels 
                                                         
            PGDM / GDM                                                                             
Impaired adult islet cell function                        Altered fetal islet cell function
                                                                                       Childhood obesity
                                            Pubertal impaired glucose tolerance
This  suggests  that diabetes can predispose to more diabetes.  However this 
process  is  potentially  preventable  by  more  effectively  normalizing  metabolism 
throughout  the  gestation  in  pre  gestational  diabetes  and  early  diagnosis  and 
correction of the metabolic disturbances of gestational diabetes mellitus.
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Metabolic changes during normal and diabetic pregnancy
The  metabolic  demands  of  the  developing  fetus  dictate  the  maternal 
metabolism with minimal catabolism during fasting which appears to be mediated 
by hormones secreted from the fetoplacental unit. The three most prominent changes 
are  progressive  insulin  resistance,  accelerated  fat  catabolism  and  fasting 
hypoglycemia. Longitudinal studies in women who have normal glucose tolerance 
have shown significant progressive alterations in all aspects of glucose metabolism 
as early as the end of the first trimester.
Insulin secretion from pancreatic beta cells normally modulates this impact. 
Insulin  secretion  progressively  increases  in  response  to  an intravenous  glucose 
challenge with advancing gestation. The increases in insulin concentration are more 
pronounced in lean than in obese women. Because insulin demands increase during 
pregnancy, women with overt or incipient diabetes are not able to make sufficient 
insulin to modulate normally the metabolic impact of the fetus and placenta.
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 When in fed state, there is “facilitated anabolism”, which is characterized by 
prolonged hyperglycemia in the mother. Along with the facilitated action of insulin, 
there  is  also  an  increased  level  of  prolactin  and  cortisol  that  result  in  insulin 
resistance.
The mild postprandial hyperglycemia, serves to increase the amount of time 
that  glucose  levels  are  elevated  above  the  basal  levels,  after  a  meal,  thereby 
increasing the flux of ingested nutrients from mother to fetus and enhancing fetal 
anabolism.  The  physiologic  changes  responsible  for  the  insulin  resistance  of 
pregnancy appear to be related to the metabolic effects of several hormones which 
include Human placental lactogen, Progesterone, Prolactin and Cortisol.
THE DIABETOGENIC POTENCY OF HORMONES IN PREGNANCY
 
        HORMONE  PEAK  ELEVATION 
(weeks)
DIABETOGENIC 
POTENCY
Prolactin 10 Weak
Estradiol 26 Very weak
Human  chorionic  somato 
mammotropin
26 Moderate
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Cortisol 26 Very strong
Progesterone 32 Strong
The metabolic changes that occur during fasting in pregnant women have been 
referred  to  as  “accelerated  starvation”,  which  include  a  reduction  in  circulating 
glucose concentration, accelerated lipolysis and ketogenesis.
Women who develop GDM are more insulin resistant  than normal  women. 
Two types of insulin resistance are seen in pregnancy. 
1. The reversible insulin resistance that occur in all pregnancies.
2. The less severe chronic insulin resistance that occur in women who are at risk 
of NIDDM.
Because insulin demands increase during pregnancy, women with limited beta 
cell  secretary  reserve  are  not  able  to  synthesize  sufficient  insulin  to  modulate 
normally the metabolic impact of the fetus and placenta. As a result, these women 
develop  significant  and  predictable  metabolic  abnormalities  of  intermediary 
metabolism that can threaten maternal and fetal well being.
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Pregnancy may disclose glucose intolerance without any clinical symptoms in 
a  predisposed  woman.  In  population  with  prevalence  of  diabetes  like  the  Nomi 
population, still birth will occur for 90% in the diabetic population disregarding the 
level  of  postprandial  blood  sugar.  Hence  the  clinical  importance  of  even  minor 
elevation  of  maternal  blood  sugar  which  is  associated  with  still  births  and 
macrosomia. 
Typical macrosomic baby
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SCREENING TESTS FOR GESTATIONAL DIABETES MELLITES
Numerous methods of screening for GDM have been used. An ideal screening 
test must be simple, easily administered, well defined, inexpensive and reproducible. 
It should have high sensitivity. It need not have high specificity that is demanded of 
a diagnostic test. 
Tests for carbohydrate intolerance during pregnancy 
1. Simple screening tests 
a) Fasting plasma glucose >105 mg/dl
b) 2hr postprandial / random plasma glucose > 120 mg/dl
2. Recommended loading tests for screening
a) 50gms glucose challenge test, 1st hr value > 140 mg/dl
b) 100gms, 3hrs, oral glucose tolerance test
c) 75gms glucose challenge test, 2nd hr value > 140 mg/dl – also diagnostic
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Glucosuria as screening test in pregnancy
Glucosuria  is  a  commonly  employed  screening  test  for  the  detection  of 
glucose intolerance. But during pregnancy, the renal threshold for glucose is often 
lowered partly to an eight fold increase in glomerular filtration rate of glucose and 
partly to an intermittent tubular defect in glucose reabsorption. 
This  has lead to the observation of  Long and Hint (1923), that glucosuria 
following an oral glucose load in a woman who has missed her period, can be used 
as a test for pregnancy. An awareness of this fact can lead to an under diagnosis of 
glucose  intolerance  during  pregnancy,  while  a  lack  of  it,  will  result  in  over 
diagnosis.
An analysis by V. Seshiah et al in 1986, on 342 pregnant women, revealed 
that,  fasting  glucosuria  has  31.58%  sensitivity,  78.95%  specificity  and  23.08% 
positive  predictive  value.  Post  glucose  load  glucosuria  has  71.93%  sensitivity, 
64.56% specificity and 28.87% positive predictive value.
Detection  of  glucose  in  urine  is  the  simplest  screening  procedure. 
Unfortunately, glocosuria is less specific as a screening test, besides being a poor 
guide to diabetic control during pregnancy.
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Fasting and random glucose studies as screening tests
Glucose values obtained without a glucose challenge have been investigated 
as screening tests. Such tests, if workable, would have the advantage of avoiding the 
administration of glucose solution. Plasma glucose concentration after an over night 
fast was approximately 10mg/dl lower in pregnant women and glucose falls by an 
additional  8 to 10mg/dl  in pregnant but not in non pregnant women,  when both 
groups  postponed  breakfast  for  6hrs.  When  the  fasting  plasma  glucose  value  is 
>105mg/dl, it suggests glucose intolerance. 
            
WHO Test:
According to WHO expert committee, 75 grams oral glucose load is given 
(Patient need not be in fasting) and a single plasma glucose value estimation at 2 
hours if more than 140 mg/dl a 3 hour OGTT is performed.  The ministry of health, 
Govt.  of  Tamilnadu  has  suggested  the  WHO  recommendation  for  universal 
screening in Tamilnadu,  which serves both as  one step screening and diagnostic 
procedure, easy to perform and also being economical.
Glucose Polymer Challenge Test:
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Glucose  polymer  is  an  inexpensive  commercially  available  glucose 
saccharide mixture containing   3% glucose, 7% maltose, 55% maltotriose and 85% 
polysaccharides.  Its osmotic load is one fifth that of glucose and has been reported 
to  be  associated  with  less  gastro  intestinal  symptoms.   A  moderate  level  of 
agreement between the results and 3 hour OGTT has also been demonstrated.  
Glycated Blood Proteins in the diagnosis of GDM:
 Glycated hemoglobin and other proteins have been investigated as screening 
tests for GDM.  Glycation is slow and almost irreversible binding of glucose or a 
phosphorylated  sugar  to  hemoglobin  or  other  blood  proteins.   Because  it  is 
dependent on the concentration of reactants and because the RBC concentration of 
glucose  approximates  that  in  extra  cellular  fluid  glycated  hemoglobin  has  been 
investigated as a diagnostic test for non gestational diabetes.  
Drawbacks:
GDM however may not be present with the same constant elevation of blood 
sugar levels as in non pregnant state.  Gravid women with GDM have fasting blood 
glucose concentration that are low, because of increased erythropoiesis, RBCs are 
younger in pregnancy, hemoglobin is less glycated and hormonal milieu changing 
rapidly from relative insulin sensitivity to that of insulin resistance as the pregnancy 
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advances, a measure of chronic hyperglycemia such as glycated hemoglobin may 
not be effective in GDM.
DIAGNOSTIC TESTS FOR GESTATIONAL DIABETES MELLITES
Oral glucose tolerance test
Women who screen positive with glucose challenge test are subjected to a 3 
hour oral glucose tolerance test (OGTT). It should be started in the morning after an 
overnight fasting of at least 8 hrs but no more than 14 hrs, following at least 3 days 
of unrestricted diet (≥ 150 grams of carbohydrate) and physical activity. Venous 
plasma glucose is  measured  at  fasting and at  1,  2 & 3 hours after  a 100 grams 
glucose  load.  Subjects  should  remain  seated  and  should  not  smoke  tobacco. 
Carpenter and Couston criteria is then applied.
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AIM OF THIS STUDY
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AIM OF THIS STUDY
AIM OF THIS STUDY:
This study compares the efficacy of  75 grams glucose challenge test  with 
fasting  and  postprandial  blood  glucose  values  in  the  screening  of  gestational 
diabetes mellitus in the general population.
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MATERIALS AND METHODS
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MATERIALS AND METHODS
SETTINGS:
The study was conducted in the high risk unit of the antenatal clinic outpatient 
department of the Institute of Social Obstetrics & Govt. Kasturba Gandhi Hospital 
for Women and Children, Triplicane, Chennai.
STUDY GROUP:
The  study  group  included  300  pregnant  women  in  GCT  group  and  300 
pregnant women in fasting & post prandial group. The group allotment was random. 
They have been followed up from the time of confirmation of pregnancy through 
delivery until one week post partum. GDM patients were followed up to 6 weeks 
post partum at which time OGTT was done to find out their glycemic status. 
 
DURATION OF STUDY:
September 2008 to August 2009.
INCLUSION CRITERIA:
44
Women with singleton gestation 
Women with no past history of GDM / DM
Not on any long term treatment for other medical illness
No previous history of treatment for GDM/DM including on meal plan
EXCLUSION CRITERIA:
Women with diabetes mellitus 
Women with multiple gestation
Women  with  other  risk  factors  like  anemia,  heart  disease,  epilepsy,  thyroid 
disorders, bad obstetric history, jaundice and auto immune disorders.
Women with past history of GDM
Those on long term medical treatment for any illness
SCREENING METHODOLOGY:
• GCT group: 
75grams  glucose  was  administered  to  women  allotted  to  the  GCT group, 
irrespective of the last meal.  Plasma glucose is estimated after two hours from a 
venous blood sample using glucose oxidase – peroxidase (GOD-POD) method. The 
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test was considered to be positive when the plasma glucose values were ≥ 140mg% 
after 2 hours of glucose administration (WHO criteria).
• FASTING / POSTPRANDIAL group:
In  women  allotted  to  the  fasting  and  post  prandial  group,  fasting  blood 
glucose and post prandial plasma glucose values were taken. The fasting value of ≥ 
95 mg% after an overnight fasting and a post postprandial value of ≥ 140 mg% at 
the end of 2 hours after meal were considered to be abnormal. 
GCT and fasting  & post  prandial  plasma glucose  testing  was done  in  the 
pregnant women allotted to the respective groups during 4 visits.
               1st visit – 8 to 10 wks
               2nd visit – 16 to 20 wks
               3rd visit – 24 to 28 wks
               4th visit – 32 to 36 wks
When they test positive, they were considered to have GDM and were treated. 
Either put on meal plan or given insulin as per their glucose values. 
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RESULTS AND ANALYSIS
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RESULTS AND ANALYSIS
This study commenced with 300 women in each group out of which 6 in each 
group could not be followed up. This has reduced the total number of test subjects to 
294 women in each group.
AGE DISTRIBUTION:
Table 1:
Age group Legend       FBS/PPBS group           GCT group
No GDM GDM Total No GDM GDM Total
    16 to 20 yrs 1 58 0 58 63 1 64
    21 to 25 yrs 2 137 1 138 125 3 128
    26 to 30 yrs 3 52 6 58 58 7 65
    31 to 35 yrs 4 39 0 39 32 4 36
    36 to 40 yrs 5 1 0 1 0 1 1
        Total 287 7 294 278 16 294
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                   FBS / PPBS group                                                                GCT group
AGE RANGE 1
5.004.003.002.001.00
Co
un
t
160
140
120
100
80
60
40
20
0
GDM 1
     .00
    1.00
             AGE RANGE 2
5.004.003.002.001.00
Co
un
t
140
120
100
80
60
40
20
0
GDM 2
     .00
    1.00
 
The mean age of the pregnant women screened was and 24.2 ± 4.5 yrs in FBS 
/ PPBS group (group 1) and 24.3 ± 4.5 yrs in GCT group (group 2). The distribution 
of women in the age group 21 to 25 yrs was relatively higher in both the groups 
(46.6% in group 1 & 42.5% in group 2). The prevalence of GDM across the age 
group of women in group 1 was ranging from 14.3 to 85.7% and that in group 2 was 
from 6.3 to 43.8%. Highest prevalence was observed in the age group of 26 to 30 
yrs in both the groups. In both groups, age was a significant parameter (p<0.001).
BMI DISTRIBUTION:
There was a consistent increase in the prevalence of GDM as BMI increased 
in both the groups and the trend was statistically significant (p < 0.001). Among the 
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GDM women, the highest prevalence was observed in women with BMI ≥ 26 kg/m2 
and it was 87.5% in group 1 and 56.3% in group 2. 
Table 2:
BMI range Legend       FBS/PPBS group           GCT group
No GDM GDM Total No GDM GDM Total
      < 18 kg/m2 1 12 0 12 7 0 7
     18 to 25 kg/m2 2 255 1 256 263 7 270
       >25 kg/m2 3 20 6 26 8 9 17
             Total 287 7 294 278 16 294
             FBS / PPBS group                                             GCT group
BMI CODE 2
3.002.001.00
Co
un
t
300
200
100
0
GDM 2
     .00
    1.00
SOCIO ECONOMIC STATUS:
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BMI RANGE 1
3.002.001.00
Co
un
t
300
200
100
0
GDM 1
     .00
    1.00
Table 3:          
Socioeconomic status Legend       FBS/PPBS group           GCT group
No GDM GDM Total No GDM GDM Total
Class 4 1 100 6 106 70 12 82
Class 5 2 187 1 188 208 4 212
Total 287 7 294 278 16 294
    
                        FBS / PPBS group                                                GCT group
        
SES RANGE 1
2.00
1.00
        
SES RANGE 2
2.00
1.00
In both these groups, GDM prevalence was significantly increased in women 
belonging to class 4 socio economic status (85.7% in group 1 and 75% in group 2). 
EDUCATIONAL STATUS:   
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The  prevalence  of  GDM  was  high  in  women  with  higher  secondary 
education.  This  is  because much of  women visiting ISO & KGH belong to this 
category.   
Table 4: 
Educational status Legend       FBS/PPBS group          GCT group
No GDM GDM Total No GDM GDM Total
Uneducated 0 0 0 0 4 0 4
Primary & high school 1 85 1 86 92 2 94
Higher secondary 2 151 4 155 154 8 162
Degree 3 51 2 53 28 6 34
Total 287 7 294 278 16 294
                           FBS / PPBS group                                           GCT group
      EDU RANGE 1
3.002.001.00
Co
un
t
200
100
0
GDM 1
     .00
    1.00
    EDU RANGE  2
3.002.001.00.00
Co
un
t
200
100
0
GDM 2
     .00
    1.00
PARITY:
  
Since the distribution of primi was more, the prevalence of GDM was also 
more in them.
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 Table 5:                
Parity Legend      FBS/PPBS group           GCT group
No GDM GDM Total No GDM GDM Total
 Primi 1 218 4 222 196 8 204
2nd gravida 2 51 3 54 60 6 66
3rd gravida 3 14 0 14 20 1 21
4th gravida 4 4 0 4 2 1 3
Total 287 7 294 278 16 294
                           FBS / PPBS group                                               GCT group
     
PARITY CODE 1
4.00
3.00
2.00
1.00
PARITY CODE 2
4.00
3.00
2.00
1.00
TIME OF DIAGNOSIS:
 Table 6:     
GDM DIAGNOSED AT FBS/PPBS group GCT group
No. of cases % %  of 
GDM
No.  of 
cases
% %  of 
GDM
    First visit (8 – 10 wks) 0 0 0 1 0.
3
6.3
    Second visit (16 – 20 wks) 0 0 0 3 1 18.7
    Third visit (24 – 28 wks) 4 1.4 57.1 8 2.
7
50
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    Fourth visit (32 – 36 wks) 3 1 42.9 4 1.
4
25
    Total no. of cases 7 2.4 100 16 5.
4
100
Hence more pregnant women were diagnosed as GDM during the third visit 
in both the groups. In GCT group, 6.3% of cases were diagnosed at 1st visit and 
18.8% at 2nd visit. This indicates a necessity for earlier screening and appropriate 
diagnosis  and  management  in  order  to  prevent  or  minimize  adverse  perinatal 
outcomes.
GESTATIONAL AGE AT DELIVERY:
Table 7:
GESTATIONAL AGE Legend       FBS/PPBS group           GCT group
No GDM GDM Total No GDM GDM Total
Term 1 263 7 270 262 15 277
Preterm 2 14 0 14 9 1 10
Post dated 3 10 0 10 7 0 7
Total no. of cases 287 7 294 278 16 294
                 FBS / PPBS group                                                       GCT group                 
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GA  AT  DELIVERY 1
4.002.001.00
Co
un
t
300
200
100
0
GDM 1
     .00
    1.00
GA AT DELIVERY 2
3.002.001.00
Co
un
t
300
200
100
0
GDM 2
     .00
    1.00
 
Most of the women with GDM delivered at term in both the groups. There 
was one preterm in GDM women of GCT group. This is due to premature rupture of 
membranes leading to preterm labour. 
TYPE OF DELIVERY: 
Table 8:
TYPE OF DELIVERY Legend       FBS/PPBS group            GCT group
No GDM GDM Total No GDM GDM Total
Labour natural 1 186 3 189 193 7 200
Assisted vaginal 2 13 0 13 16 0 16
Caesarean section 3 88 4 92 69 9 78
Total 287 7 294 278 16 294
               FBS/PPBS group                                                     GCT group
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050
100
150
200
LN AV LSCS
0
1
   
0
50
100
150
200
LN AV LSCS
0
1
The total caesarean delivery rate was 31.29% in group 1 and 26.53% in group 
2. This might be due to the higher number of previous caesarean rates. There were 
61 women with previous caesarean in group 1 and 65 women in group 2.
BIRTH WEIGHT:
Table 9:
Range of weight Legend       FBS/PPBS group           GCT group
No GDM GDM Total No GDM GDM Total
< 2.5 kg 1 23 0 23 26 1 27
2.5 to 4 kg 2 259 7 266 250 15 265
> 4 kg 3 5 0 5 2 0 2
Total 287 7 294 278 16 294
                    FBS/PPBS group                                                        GCT group              
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WEIGHT  RANGE 1
3.002.001.00
C
ou
nt
300
200
100
0
GDM 1
     .00
    1.00
     WEIGHT  RANGE 2
3.002.001.00
Co
un
t
300
200
100
0
GDM 2
     .00
    1.00
The mean birth weight of babies in FBS / PPBS group was 3.01 kg and that of 
babies in GCT group was 2.93 kg. There were 5 cases of macrosomic babies in the 
non GDM women of group 1. Hence for the last 100 women of group 1, GCT was 
done at 28 wks. The sensitivity of FBS / PPBS testing was found to be only 60%.  
Since most of our women come from economically weaker sections of the 
society,  the  birth  weight  also  is  somewhat  lower  than  the  average  birth  weight. 
Hence there is more number of babies with birth weight <2.5 Kg.
MANAGEMENT:  
Out of the 7 GDM patients in group 1, 5 were on meal plan and 2 were put on 
insulin. Out of the 16 GDM patients in group 2, 10 were on meal plan and 6 were 
put on insulin.
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Table 10:
Management Legend       FBS/PPBS group GCT group
No GDM GDM Total No GDM GDM Total
No treatment 0 287 0 287 278 0 278
Meal plan 1 0 5 5 0 10 10
Insulin 2 0 2 2 0 6 6
Total 287 7 294 278 16 294
                        FBS/PPBS group                                                          GCT group 
MGT RANGE 1
2.001.00.00
Co
un
t
400
300
200
100
0
GDM 1
     .00
    1.00
    MGT  CODE 2
2.001.00.00
Co
un
t
300
200
100
0
GDM 2
     .00
    1.00
NEONATAL ADMISSION:
 
Table 11:   
Admission status Legend       FBS/PPBS group           GCT group
No GDM GDM Total No GDM GDM Total
Not admitted 0 246 4 250 255 14 269
Admitted 1 41 3 44 23 2 25
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Total 287 7 294 278 16 294
                  FBS/PPBS group                                               GCT group
0
50
100
150
200
250
0 1
0
1
0
50
100
150
200
250
300
0 1
0
1
The reasons for admission were preterm, low birth weight, sepsis, transient 
tachypnea  of  new  born,  hyperbillirubinemia,  respiratory  distress  syndrome, 
meconium  aspiration,  birth  asphyxia  and  hypoglycemia.  There  were  8  cases  of 
hypoglycemia in group 1 and 2 cases in group 2. Plasma glucose levels were tested 
in all the babies of GDM mothers and if found to be normal, the babies were handed 
over to the mother with instructions to start early breast feed. 
FINDINGS ON FOLLOW UP:
There  were  2  patients  with  LSCS  wound  infection  and  1  patient  with 
episiotomy wound gaping in group 1 women who did not have GDM. 
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In both the groups, GDM patients had normal plasma glucose levels on follow 
up. Only one woman in Group 2 continued to have increased levels of blood glucose 
even after 6 weeks and she is being managed appropriately. 
DISCUSSION
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DISCUSSION
Gestational  diabetes  mellitus  (GDM)  is  the  most  common  medical 
complication of pregnancy. GDM occurs in women who have insulin resistance and 
a relative impairment of insulin secretion. These women have a significant risk of 
developing diabetes later in life. Identifying this group of women is important in not 
only preventing perinatal morbidity but also improving long-term outcomes for the 
mothers and their children.
Proponents  of  universal  screening  for  GDM  emphasize  that  pregnancy 
provides a unique opportunity to diagnose a disease that has significant short- and 
long-term implications for both mothers and children. 
In the study group that includes 600 pregnant women, 300 women randomly 
allocated to undergo either a glucose challenge test or a fasting and post prandial 
plasma glucose estimation at different periods of gestation, mean age was 24.3 +/- 
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4.5 yrs, mean BMI was 21.95 +/- 2.5 kg/m2, 70.4% were primigravida and 29.6% 
were multigravida. The results of the present study are compared with the results of 
various other published studies.
Comparison of the prevalence of GDM: 
The prevalence of GDM ranges between 1–14% of patients, depending on the 
population described and the criteria used for diagnosis. The prevalence of GDM 
was 2.4% in the fasting post prandial group. It has identified 7 cases of GDM among 
the 300 pregnant women allotted to the fasting & post prandial group (group 1). 
The prevalence of GDM was 5.4% in the GCT group. It has identified 16 
cases of GDM among the 300 pregnant women allotted to the GCT group (group 2). 
 
                      Prevalence of GDM
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Author  Location
Prevalence 
(%)
Abell, Beischer27 Australia 0.7
Beischer28 India 15
Ranchod29 India 3.8
O’Sullivan30 Boston 2.5
Magee31 Seattle 3.2–5.0
Dooley32 Chicago 3.5–5.5
Sacks33 Los Angeles 3.4
Berkowitz34 Manhattan 4.6
Murphy35 Alaska 5.8
Nahum36 Los Angeles 7.1
Mestman37 Los Angeles 12.3
Benjamin38 Zuni, New Mexico       14.3
Present study 5.4
Age distribution:
In the present study, the mean age of patients without GDM was 24.15 ± 4.5 
yrs and that of those with GDM was 26.76 ± 4.4 yrs. 
Author Mean age of  pts. 
without  GDM
Mean age of  pts. 
with GDM
p value 
RUN MEI MA et al39 28.4 - 3.6 yrs 29.6 - 4.0 yrs < 0.001
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BMI distribution:
Shin Y. Kim et  al40,  reported the proportions of  gestational  diabetes cases 
attributable  to  overweight,  obesity,  and extreme obesity  were  15.4%, 9.7%, and 
21.1%, for a total of 46.2%. "In other words, if all women with a BMI of 25 or 
greater had a GDM risk equal to that of women in the normal BMI category, nearly 
half of GDM cases could be prevented. Lifestyle interventions to reduce BMI have 
the potential to lower GDM risk," she commented. According to Ogonowski and 
Miazgowski  et  al41,  the cut  off  point  for  BMI as a risk indicator  for  GDM was 
22.85kg/m2 (odds ratio = 1.91; 95% confidence interval 1.5-2.1; sensitivity 47.8%, 
specificity 65.9%). Significant relationships between pregravid BMI and GDM were 
found and BMI was the strongest predictor for GDM treated with insulin. In our 
study, the mean BMI of patients with GDM was 26.02 kg/m2 and for those without 
GDM was 21.75 kg/m2. 
Socio economic status: 
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Socioeconomic status was inversely associated with risk of GDM. The risk of 
GDM  was  approximately  two-thirds  higher  in  women  living  in  the  lowest 
socioeconomic postcodes compared with women in the highest group. The inverse 
relationship between socioeconomic status and risk of GDM was apparent across all 
ethnic groups when data were stratified by maternal region of birth, with women in 
the bottom half of SEIFA postcodes having at least  a  30% higher risk of GDM 
relative to that for the highest quartile. Women in the lowest socioeconomic group 
aged >40 years had a risk of 10.26 (95% CI 8.75–12.03) compared with that of 
women aged 20–24 years residing the highest quartile of SEIFA postcodes in the 
study conducted by Vibeke Anna et al42. 
According to Timothy D. Dye et al43, women of higher socioeconomic status 
who were obese and did not exercise were at a significantly elevated risk of GDM 
compared with their counterparts of lower socioeconomic status.  In this study, the 
incidence of GDM was high in women belonging to class 4 socio economic status in 
both groups (85.7% in group 1 & 75% in group 2).
Educational status:
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The prevalence of GDM ranged from 1.05% (95% CI - 0.60, 1.70) in the less 
educated  to  2.10%  (95%,  CI 1.34,  3.13),  in  the  more  educated  neighborhood 
according to  M. Janghorbani et  al44.  In  this  study,  1.4% of  patients  with higher 
secondary education and 0.7% of patients with some graduation had GDM in group 
1 and similarly 2.7% and 2% in group 2 had GDM.
Parity:
 
According to D. Simmons et al45, GDM was less common among women with 
a parity of 1 to 2 (OR = 0.64) and 3 to 4 (OR = 0.72) than in grand multiparous 
women. Vibeke Anna et al found women who had reported a previous pregnancy of 
>  20  weeks’  gestation  had  a  small  but  significantly  reduced  risk  of  GDM  in 
subsequent pregnancies. There was nearly a 10% reduction in risk in women who 
had  a  previous  pregnancy  compared  with  that  in  women  having  their  first 
pregnancy. A similar small protective effect was also apparent among women who 
had  two  or  more  previous  pregnancies.  In  our  study,  57.1%  of  GDM  was  in 
Primigravidas in group 1 and 50% in group 2.
Time of diagnosis: 
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According to Seshiah et al, among the GDM women detected in his study,
 35.4% were < 24 weeks of gestation and this included 12.4% of GDM women < 16 
weeks of gestation and remaining 64.6 % more than 24 weeks of gestation. 2-2.5 per 
cent  of  the  gestational  diabetes  prevalence  recorded  during  the  Tamil  Nadu 
programme was found in the 16th week, while 2.5-3 per cent cases were detected 
during the 24th week and around 3 per cent in the 32nd week by Seshiah et al in the 
Background paper for the Guidelines for GDM Screening in Tamil Nadu46. In our 
study, the GDM prevalence at <24 wks was 25.1%, at 24 wks was 50% and that at 
>32 wks was 25%. Hence early screening for glucose intolerance and care is likely 
to result in the reduction of some of the hyperglycemia-related complications. 
Gestational age at delivery:
Yariv Yogev et al47 found no difference in the rate of spontaneous preterm 
delivery (sPTD) in GDM (163/1,526, 10.7%) in comparison to non-GDM patients 
(1193/10,560,  11.3%,  P = 0.2).  GDM patients  with  sPTD were  characterized  by 
higher glucose values in the OGTT and higher mean blood glucose (114 ± 16 vs. 
106 ± 14, P < 0.0001). In our study, nearly all patients with GDM delivered at term. 
 
Birth weight:
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According to R G Moses et al48, for women with GDM, the mean (± 1 SD) 
birth weight was 3293 ± 493 g. Their values were not significantly different from 
the matched group, which had a birth weight of 3315 ± 460 g. In our study,  the 
mean birth weight of IDM babies was 3.10 and those of normal women was 3.01 ± 
0.5 kg in group 1 and that in group 2 was 2.99 and 2.92 ± 0.4 kg respectively. 
Intrapartum and neonatal characteristics:
 
According to Jana Kaida Silva et al49, statistically significant differences in 
type  of  delivery,  neonatal  weight  /  macrosomia,  hypoglycemia,  and 
hyperbilirubinemia  were  found  among  ethnic  groups.  Neonates  born  to  Native 
-Hawaiian  /  Pacific  -  Islander  and  Caucasian  women  were  more  likely  to  have 
hypoglycemia  whereas  neonates  born to  Native  –  Hawaiian  /  Pacific  -  Islander, 
Filipino, and Caucasian women were more likely to have hyperbilirubinemia than 
neonates from other ethnic groups. Native – Hawaiian / Pacific - Islander women 
were also more likely to have neonates with macrosomia than women from the other 
ethnic groups. Chinese women were more likely to have assisted vaginal delivery 
(vacuum extraction or forceps) but were least likely to have had cesarean section 
compared with women from the other ethnic groups.
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In  our  study,  there  were  no  assisted  vaginal  deliveries  in  both  groups, 
whereas,  57.2% of  GDM patients  delivered  by  caesarean  and  42.8% by  labour 
natural in group 1 and 56.2% and 43.75% in group 2. 42.9% of infants of diabetic 
mother were admitted in group 1 and the same in group 2 was 12.5%.
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SUMMARY
SUMMARY
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This is a comparative study of the efficacy of 75 grams glucose challenge test 
with fasting and postprandial blood glucose values in the screening of gestational 
diabetes mellitus in the general population, carried out in the high risk unit of the 
antenatal clinic outpatient department of the Institute of Social Obstetrics & Govt. 
Kasturba Gandhi Hospital for Women and Children, Triplicane, Chennai.
The  study  group  consisted  of  600  apparently  normal  pregnant  women, 
randomly allotted to FBS / PPBS or 75 grams GCT group, 300 each. The respective 
tests were done on 4 visits. 1st visit – 8 to 10 wks, 2nd visit – 16 to 20 wks, 3rd visit 
– 24 to 28 wks and 4th visit – 32 to 36 wks. Patients who have GDM were given 
appropriate treatment.  
The prevalence of GDM was 2.4% in FBS / PPBS group and 5.4%    in GCT 
group. GCT has identified 25% of cases prior to 24 weeks gestation, 50% of cases at 
between  24  to  28  weeks  and  25%  of  cases  after  32  weeks.  Hence  the  earlier 
diagnosis  allows  better  and  effective  management,  thereby  preventing  adverse 
obstetric and perinatal outcomes. Also this is indicative that GDM reveals itself at 
all 3 trimesters.
The mean age of the pregnant women screened was 24.2 ± 4.5 yrs in FBS / 
PPBS group and 24.3 ± 4.5 yrs in GCT group. Highest prevalence of GDM was 
71
observed  in  the  age  group  of  26  to  30  yrs  in  both  the  groups.  The  pattern  of 
significant  increase in prevalence (p < 0.001) of GDM as the age increases was 
observed in both the groups.
Among the GDM women,  the highest  prevalence was observed in women 
with BMI ≥ 26 kg/m2 and it was 87.5% in FBS / PPBS group and 56.3% in GCT 
group. Hence in both the groups, there was a significant (p < 0.001) increase in the 
risk of acquiring GDM as the BMI increases beyond 26. 
The incidence of GDM was more in Primigravida.  Higher prevalence was 
also noted in women belonging to class 4 socioeconomic status and in those with 
higher secondary education. They were managed with either meal plan or insulin 
according to their glucose levels.
Most  of  the  patients  with  GDM delivered  at  term by labor  natural  or  by 
caesarean section. There were no assisted vaginal deliveries in this group.
There was no significant  difference  in  the birth weight  of  babies  between 
normal women and in those with GDM in both groups. Hence for 100 patients in 
group 1, GCT was done at 28 weeks and the sensitivity of screening with fasting 
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and post prandial plasma glucose was only 60% when compared to screening with 
75 grams glucose challenge test.
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CONCLUSION
CONCLUSION
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To  conclude,  75  grams  glucose  challenge  test  done  as  per  WHO criteria 
serves both as one step screening and diagnostic procedure, is easy to perform and 
also economical and has detected more number of GDM cases. The same has been 
recommended  for  screening  in  all  pregnant  women  by  “THE  MINISTRY  OF 
HEALTH and FAMILY WELFARE, GOVERNMENT OF TAMIL NADU”.
SCREENING AND SUBSEQUENT TREATMENT STARTED IN THE 
EARLY WEEKS OF PREGNANCY HAS THE POTENTIAL TO DETECT 
CASES  EARLY  AND  CAN  PREVENT  OR  MINIMIZE  ADVERSE 
OBSTETRIC AND PERINATAL OUTCOMES.  
As the age increases,  the risk of acquiring GDM also increases.  Similarly 
when BMI is ≥ 26, GDM risk increases.  
Screening  with  fasting  and  post  prandial  plasma  glucose  has  only  60% 
sensitivity when compared to screening with 75 grams glucose challenge test. 
Hence Glucose Challenge Test with 75 grams oral glucose irrespective of last 
meal for all pregnant women appear to be a simple, effective and easily reproducible 
screening method for early diagnosis of GDM.
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ANNEXURE
ANNEXURE
COMPARITIVE STUDY OF THE EFFICACY OF 75 GRAMS GLUCOSE 
CHALLENGE TEST WIYH FASTING AND POSTPRANDIAL BLOOD 
GLUCOSE VALUES IN THE SCREENING OF GESTATIONAL DIABETES 
MELLITUS IN THE GENERAL POPULATION
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Name of patient                     :
Age                                        :
OP No.                                   :
Socio Economic Status          :      I           II            III            IV         V
Education                               :
Address                            :
Other risk factors                   :   Present / Absent
Obstetric Formula                  :  
BMI                                        : 
SCREENING FOR GDM 
      
TEST  VISIT 1 VISIT 2 VISIT 3 VISIT 4
FBS / PPBS
                                    
                                          Or
TES VISIT 1 VISIT 2 VISIT 3 VISIT 4
89
T  
GCT 
Management                           :    Meal Plan
                                           Drugs (Specify)
MATERNAL AND FETAL OUTCOME
•   Delivered at : Term / Pre term / Post EDD
•   Type of delivery : SVD / IVD/ CS
•   Weight of the baby :
•   Whether admitted in NICU :  Yes / No
•   Immediate follow up of the mother
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